Pilot study of an internet-based pain coping skills training program for patients with systemic Lupus Erythematosus.
Coping
Pain
Systemic lupus Erythematosus
Journal
BMC rheumatology
ISSN: 2520-1026
Titre abrégé: BMC Rheumatol
Pays: England
ID NLM: 101738571
Informations de publication
Date de publication:
17 Jun 2021
17 Jun 2021
Historique:
received:
23
12
2020
accepted:
23
03
2021
entrez:
17
6
2021
pubmed:
18
6
2021
medline:
18
6
2021
Statut:
epublish
Résumé
Patients with Systemic Lupus Erythematosus (SLE) often experience pain and other symptoms that negatively impact quality of life. Interventions that enhance the use of behavioral and cognitive coping strategies may lead to improved outcomes among patients with SLE. Pain coping skills training (PCST) programs have been shown to improve outcomes among patients with other rheumatic conditions, but there have been no trials of PCST among patients with SLE. This study was a preliminary assessment of the feasibility and efficacy of painTRAINER, an automated, internet-based PCST program, among patients with SLE. Participants (n = 60) with SLE from one health care system were randomly assigned with equal allocation to painTRAINER or a wait list control group. PainTRAINER involves 8 modules; participants were instructed to complete one module weekly, along with practice activities for each cognitive or behavioral coping skill. Outcome measures were assessed at baseline and 9-week follow-up, including the Pain Catastrophizing Scale, PROMIS Subscales (Pain Interference, Physical Function, Sleep Disturbance, Anxiety, Depression, Fatigue and Participation), and the LupusPRO questionnaire. Mean changes in outcomes from baseline to follow up and Cohen's d effect sizes were computed. Effect sizes for the painTRAINER group (relative to the wait list group) were small, with changes being greatest for the PROMIS Depression score (d = - 0.32). Among those randomized to the painTRAINER group, 50% accessed the program ("painTRAINER users"). Most of those who did not access the program stated that they did not receive instructions via email. Effect sizes for "painTRAINER users" (relative to wait list) were larger than for the whole painTRAINER group: Pain Catastrophizing d = - 0.60, PROMIS Pain Interference d = - 0.3., PROMIS Depression d = - 0.44, LupusPRO Health-Related Quality of Life d = 0.30. PainTRAINER users reported meaningful improvements in multiple physical and psychological outcomes, supporting the potential of PCST programs to benefit individuals with SLE. However, strategies are needed to improve engagement with the program and tailor content to comprehensively address key SLE symptoms and challenges. NCT03933839 , May 1, 2019.
Sections du résumé
BACKGROUND
BACKGROUND
Patients with Systemic Lupus Erythematosus (SLE) often experience pain and other symptoms that negatively impact quality of life. Interventions that enhance the use of behavioral and cognitive coping strategies may lead to improved outcomes among patients with SLE. Pain coping skills training (PCST) programs have been shown to improve outcomes among patients with other rheumatic conditions, but there have been no trials of PCST among patients with SLE. This study was a preliminary assessment of the feasibility and efficacy of painTRAINER, an automated, internet-based PCST program, among patients with SLE.
METHODS
METHODS
Participants (n = 60) with SLE from one health care system were randomly assigned with equal allocation to painTRAINER or a wait list control group. PainTRAINER involves 8 modules; participants were instructed to complete one module weekly, along with practice activities for each cognitive or behavioral coping skill. Outcome measures were assessed at baseline and 9-week follow-up, including the Pain Catastrophizing Scale, PROMIS Subscales (Pain Interference, Physical Function, Sleep Disturbance, Anxiety, Depression, Fatigue and Participation), and the LupusPRO questionnaire. Mean changes in outcomes from baseline to follow up and Cohen's d effect sizes were computed.
RESULTS
RESULTS
Effect sizes for the painTRAINER group (relative to the wait list group) were small, with changes being greatest for the PROMIS Depression score (d = - 0.32). Among those randomized to the painTRAINER group, 50% accessed the program ("painTRAINER users"). Most of those who did not access the program stated that they did not receive instructions via email. Effect sizes for "painTRAINER users" (relative to wait list) were larger than for the whole painTRAINER group: Pain Catastrophizing d = - 0.60, PROMIS Pain Interference d = - 0.3., PROMIS Depression d = - 0.44, LupusPRO Health-Related Quality of Life d = 0.30.
CONCLUSIONS
CONCLUSIONS
PainTRAINER users reported meaningful improvements in multiple physical and psychological outcomes, supporting the potential of PCST programs to benefit individuals with SLE. However, strategies are needed to improve engagement with the program and tailor content to comprehensively address key SLE symptoms and challenges.
TRIAL REGISTRATION
BACKGROUND
NCT03933839 , May 1, 2019.
Identifiants
pubmed: 34134788
doi: 10.1186/s41927-021-00191-6
pii: 10.1186/s41927-021-00191-6
pmc: PMC8210367
doi:
Banques de données
ClinicalTrials.gov
['NCT03933839']
Types de publication
Journal Article
Langues
eng
Pagination
20Subventions
Organisme : NIA NIH HHS
ID : T35 AG038047
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002489
Pays : United States
Références
Arthritis Rheum. 2006 Jun 15;55(3):427-33
pubmed: 16739209
Pain. 2010 Jul;150(1):173-182
pubmed: 20554116
Pain. 2018 Sep;159(9):1833-1842
pubmed: 29794609
Lupus. 2018 Apr;27(5):728-737
pubmed: 29087259
Lupus. 2011 Aug;20(9):893-903
pubmed: 21562019
Pain. 2012 Jun;153(6):1199-1209
pubmed: 22503223
Neuroimmunomodulation. 2006;13(5-6):283-93
pubmed: 17709950
Psychother Psychosom. 2010;79(2):107-15
pubmed: 20090397
Pain. 1983 Sep;17(1):33-44
pubmed: 6226916
Arthritis Care Res (Hoboken). 2012 Sep;64(9):1334-40
pubmed: 22505314
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Nat Rev Rheumatol. 2011 Apr;7(4):216-24
pubmed: 21283147
Arthritis Rheum. 2004 Aug 15;51(4):625-34
pubmed: 15334437
Am J Med Sci. 2012 Oct;344(4):274-82
pubmed: 22996139
Health Educ Res. 2005 Aug;20(4):439-47
pubmed: 15598664
Lupus. 2018 Apr;27(4):681-687
pubmed: 29310537
J Pain. 2004 Aug;5(6):304-16
pubmed: 15336635
Pain Res Manag. 2008 Sep-Oct;13(5):401-6
pubmed: 18958312
Pain. 2019 Jun;160(6):1297-1307
pubmed: 30913165
BMC Musculoskelet Disord. 2020 Aug 14;21(1):545
pubmed: 32795282
Lupus Sci Med. 2015 Nov 12;2(1):e000113
pubmed: 26629351
Nat Rev Dis Primers. 2016 Jun 16;2:16039
pubmed: 27306639
Health Psychol. 2007 May;26(3):241-50
pubmed: 17500610
J Med Internet Res. 2014 Dec 19;16(12):e245
pubmed: 25532216
Pain. 2014 Sep;155(9):1743-1754
pubmed: 24865795
Pain. 2015 May;156(5):837-848
pubmed: 25734997
Contemp Clin Trials Commun. 2020 Jan 21;17:100527
pubmed: 32083219
Arthritis Care Res. 1996 Aug;9(4):279-91
pubmed: 8997917
Arthritis Care Res (Hoboken). 2017 Sep;69(9):1312-1321
pubmed: 28029753
Ann Rheum Dis. 2005 Nov;64(11):1618-23
pubmed: 15829575
J Pain Symptom Manage. 2009 May;37(5):863-72
pubmed: 19041218
Ann Intern Med. 2017 Apr 4;166(7):453-462
pubmed: 28241215
Arthritis Rheum. 2003 Apr 15;49(2):156-63
pubmed: 12687505
Arthritis Rheum. 2004 Jun;50(6):1832-41
pubmed: 15188360